Decipher Labs Valuation

Is 524752 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 524752 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 524752's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 524752's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 524752?

Key metric: As 524752 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 524752. This is calculated by dividing 524752's market cap by their current earnings.
What is 524752's PE Ratio?
PE Ratio	18.8x
Earnings	₹8.34m
Market Cap	₹158.67m

524752 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.3x
Enterprise Value/EBITDA	5.2x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 524752's PE Ratio compare to its peers?

The above table shows the PE ratio for 524752 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	37x
543500 Evoq Remedies	43.2x	n/a	₹198.0m
524768 Emmessar Biotech & Nutrition	26.2x	n/a	₹229.8m
542678 Cian Healthcare	47.7x	n/a	₹122.7m
531210 Colinz Laboratories	30.8x	n/a	₹154.9m
524752 Decipher Labs	18.8x	n/a	₹158.7m

Price-To-Earnings vs Peers: 524752 is good value based on its Price-To-Earnings Ratio (18.8x) compared to the peer average (37x).

Price to Earnings Ratio vs Industry

How does 524752's PE Ratio compare vs other companies in the IN Pharmaceuticals Industry?

2 Companies	Price / Earnings	Estimated Growth	Market Cap
INDSWFTLAB Ind-Swift Laboratories	1.6x	n/a	US$69.13m
524652 Ind-Swift	2.2x	n/a	US$14.23m

No more companies available in this PE range

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 524752 is good value based on its Price-To-Earnings Ratio (18.8x) compared to the Indian Pharmaceuticals industry average (36x).

Price to Earnings Ratio vs Fair Ratio

What is 524752's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

524752 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	18.8x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 524752's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.